Pause In Johnson & Johnson COVID Vaccine Could Have Consequences for Senior Living Providers

April 13, 2021 by Senior Housing News

Senior Housing News reports, “Federal health officials are recommending a halt in administering the Johnson & Johnson Covid-19 vaccine as they review a small number of reported cases of a rare and severe type of blood clot. A prolonged pause on the vaccine could affect vaccination efforts in senior living communities, but it’s not clear by how much or how long such a disruption may last.”

At our sister company, Consonus Healthcare, this pause will not halt vaccinations. Consonus Pharmacy is fully stocked with the Pfizer vaccine and our vaccine continuity program will continue without interruption. 

Senior Housing News spoke with Consonus CEO, Phil Fogg, about the J&J pause and how it impacts Senior Living Providers.

The effects of the vaccine pause vary by situation, according to Phil Fogg, Jr., CEO of Milwaukie, Oregon-based Marquis Companies, along with its in-house long-term care pharmacy, Consonus Pharmacy.

Read the full article on Senior Housing News